Cartesiantherapeutics
2 known investors
Cartesian Therapeutics develops mRNA-based cell therapies for autoimmune diseases. The company is a clinical-stage biotech firm focused on advancing immunology treatments through its proprietary mRNA platform.
BiotechHealthtech